Amazon launched an online pharmacy Friday in Bangalore, India, which will sell herbal remedies and drugs, according to Reuters.
The virtual pharmacy will be able to sell over-the-counter and prescription drugs as well as Indian herbal cures and fundamental health services, according to Reuters. India is also looking to complete regulations concerning the sale of drugs from online pharmacies, Reuters reported.
Amazon saw a business increase after coronavirus restrictions forced many to resort to online shopping, according to the Wall Street Journal. (RELATED: Bezos Has Record-High Single-Day Wealth Increase, Adds $13 Billion)
The rise of online drug providers, such as Medlife, have threatened offline drug provider companies, according to Reuters. Trade groups voiced that online drug providers will create a problem with medicine sales, and take business away from small retailers.
“Amazon’s customer base is very high, so we are bound to lose business,” Yash Aggarwal, legal head of South Chemists and Distributors Association in New Delhi said, according to Reuters.
“There are 5 million families dependent on this (offline) trade,” Aggarwal said, according to Reuters. Aggarwal added that the South Chemists and Distributors Association in New Delhi will speak with the Indian government about Amazon’s online pharmacy.

The logo of Amazon is seen at the company logistics center in Lauwin-Planque, northern France, April 22, 2020. REUTERS/Pascal Rossignol/File Photo
CEO Jeff Bezos of Amazon added $13 billion to his net worth on July 20, the Bloomberg Billionaire Index reported, according to Fox Business. Bezos’ wealth went up past $189 billion so far in 2020, the Bloomberg index reported, according to Fox Business.
Amazon’s Public Relations did not immediately respond to the Daily Caller News Foundation’s email request for comment.
All content created by the Daily Caller News Foundation, an independent and nonpartisan newswire service, is available without charge to any legitimate news publisher that can provide a large audience. All republished articles must include our logo, our reporter’s byline and their DCNF affiliation. For any questions about our guidelines or partnering with us, please contact licensing@dailycallernewsfoundation.org.